SCHEMBL7964265

SCHEMBL7964265

COc1cccc(C2=CCCCC2Cc2nc(-c3ccccc3)c(-c3ccccc3)o2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.52
RXRB P28702 1/20 0.52
PTGER4 P35408 5/20 0.51
PTGIR P43119 4/20 0.51
PTGER3 P43115 1/20 0.51
PTGER1 P34995 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.42
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
PPARD Q03181 1/20 0.38
KMT2A Q03164 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7949263 0.84 PTGER4 (0.58) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7479094 0.83 PTGIR (0.73) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL9006885 0.83 PTGIR (0.73) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7949957 0.83 PTGIR (0.73) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7959999 0.82 PTGER4 (0.70) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7490131 0.80 PTGIR (0.69) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7495199 0.79 PTGIR (0.68) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7495210 0.79 PTGIR (0.68) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7480950 0.78 PTGIR (0.65) RXRARXRBPTGER4PTGIRPTGER3
SCHEMBL7489516 0.77 PTGER4 (0.56) RXRARXRBPTGER4PTGIRPTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed